CTOs on the Move


 
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nymox.com
  • Heights Plaza 777 Terrace Avenue
    Hasbrouck Heights, NJ USA 07604
  • Phone: 800.936.9669

Executives

Name Title Contact Details

Funding

Nymox raised $16.3M on 04/12/2018

Similar Companies

HealthFrontier (Canada)

HealthFrontier (Canada), Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Coventry Court Health Ctr

Coventry Court Health Ctr is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clear Catheter Systems

Clear Catheter Systems is a Bend, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Marquis Health Consulting Services

Marquis Health Consulting Services provides administrative and consulting services to skilled nursing facilities and Senior Housing communities throughout the United States Eastern Seaboard.

Carolinas Shared Services

Carolinas Shared Services is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.